Adrian Cabrera

Direttore/Membro del Consiglio presso

Kiniciti

Finance

Consumer Services

Technology Services

Profilo

Adrian Cabrera is currently a Principal at Welsh, Carson, Anderson & Stowe since 2022, and a Board Member at Kiniciti since 2021.
Mr. Cabrera completed undergraduate studies at Florida International University in 2013.

Posizioni attive di Adrian Cabrera

Società	Posizione	Inizio
Welsh, Carson, Anderson & Stowe Welsh, Carson, Anderson & Stowe Investment ManagersFinance WCAS invest in companies located in the United States. The firm targets companies operating in the fields of healthcare and technology sectors. It provide financing for acquisitions and growth capital requirements.	Investitore di Private Equity	01/07/2019
Kiniciti Kiniciti Information Technology ServicesTechnology Services Develops resources, expertise and capital technology platform to help partner companies accelerate the advancement and adoption of cell & gene therapies	Direttore/Membro del Consiglio	01/01/2021

Tutte le posizioni attive di Adrian Cabrera

Formazione di Adrian Cabrera

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Adrian Cabrera

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	3
Welsh, Carson, Anderson & Stowe Welsh, Carson, Anderson & Stowe Investment ManagersFinance WCAS invest in companies located in the United States. The firm targets companies operating in the fields of healthcare and technology sectors. It provide financing for acquisitions and growth capital requirements.	Finance
Florida International University Florida International University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kiniciti Kiniciti Information Technology ServicesTechnology Services Develops resources, expertise and capital technology platform to help partner companies accelerate the advancement and adoption of cell & gene therapies	Technology Services